Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

恩帕吉菲 医学 内科学 肾功能 糖尿病 管球反馈 内分泌学 肾脏疾病 卡格列净 达帕格列嗪 心脏病学 血压 心力衰竭 心肌梗塞 2型糖尿病 泌尿科
作者
Hiddo J.L. Heerspink,Bruce A. Perkins,DAVID H. FITCHETT,Mansoor Husain,David Z.I. Cherney
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:134 (10): 752-772 被引量:1533
标识
DOI:10.1161/circulationaha.116.021887
摘要

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including empagliflozin, dapagliflozin, and canagliflozin, are now widely approved antihyperglycemic therapies. Because of their unique glycosuric mechanism, SGLT2 inhibitors also reduce weight. Perhaps more important are the osmotic diuretic and natriuretic effects contributing to plasma volume contraction, and decreases in systolic and diastolic blood pressures by 4 to 6 and 1 to 2 mm Hg, respectively, which may underlie cardiovascular and kidney benefits. SGLT2 inhibition also is associated with an acute, dose-dependent reduction in estimated glomerular filtration rate by ≈5 mL·min(-1)·1.73 m(-2) and ≈30% to 40% reduction in albuminuria. These effects mirror preclinical observations suggesting that proximal tubular natriuresis activates renal tubuloglomerular feedback through increased macula densa sodium and chloride delivery, leading to afferent vasoconstriction. On the basis of reduced glomerular filtration, glycosuric and weight loss effects are attenuated in patients with chronic kidney disease (estimated glomerular filtration rate <60 mL·min(-1)·1.73 m(-2)). In contrast, blood pressure lowering, estimated glomerular filtration rate, and albuminuric effects are preserved, and perhaps exaggerated in chronic kidney disease. With regard to long-term clinical outcomes, the EMPA-REG OUTCOME trial (Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes) in patients with type 2 diabetes mellitus and established cardiovascular disease randomly assigned to empagliflozin versus placebo reported a 14% reduction in the primary composite outcome of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and >30% reductions in cardiovascular mortality, overall mortality, and heart failure hospitalizations associated with empagliflozin, even though, by design, the hemoglobin A1c difference between the randomized groups was marginal. Aside from an increased risk of mycotic genital infections, empagliflozin-treated patients had fewer serious adverse events, including a lower risk of acute kidney injury. In light of the EMPA-REG OUTCOME results, some diabetes clinical practice guidelines now recommend that SGLT2 inhibitors with proven cardiovascular benefit be prioritized in patients with type 2 diabetes mellitus who have not achieved glycemic targets and who have prevalent atherosclerotic cardiovascular disease. With additional cardiorenal protection trials underway, sodium-related physiological effects of SGLT2 inhibitors and clinical correlates of natriuresis, such as the impact on blood pressure, heart failure, kidney protection, and mortality, will be a major management focus.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Youdge的应助被hc采纳,获得10
刚刚
Lalala完成签到,获得积分10
1秒前
TSW发布了新的文献求助10
1秒前
爆米花的应助被脚踏实地i采纳,获得30
1秒前
rd发布了新的文献求助10
2秒前
霸气雯发布了新的文献求助20
3秒前
4秒前
星辰大海的应助被xx采纳,获得10
6秒前
郑睿涛发布了新的文献求助10
6秒前
8秒前
wei完成签到 ,获得积分10
8秒前
李明发布了新的文献求助10
10秒前
10秒前
lfz完成签到,获得积分10
11秒前
rd完成签到,获得积分10
12秒前
爆米花的应助被牧百川采纳,获得10
12秒前
楠猫要西柚完成签到,获得积分20
12秒前
官方电话完成签到 ,获得积分10
12秒前
明理的以亦完成签到,获得积分10
13秒前
wanci的应助被renn采纳,获得20
14秒前
飞飞鱼完成签到,获得积分10
14秒前
学术新星发布了新的文献求助10
14秒前
15秒前
Ren发布了新的文献求助10
15秒前
15秒前
传奇3的应助被和蔼的茅草根采纳,获得10
16秒前
风里等你完成签到,获得积分10
17秒前
18秒前
zhu完成签到,获得积分10
18秒前
18秒前
serena完成签到,获得积分10
20秒前
21秒前
FashionBoy的应助被ZZSY采纳,获得10
22秒前
科研通AI6.4的应助被TSW采纳,获得20
22秒前
23秒前
Lian完成签到,获得积分10
24秒前
郑睿涛发布了新的文献求助10
24秒前
btbu2015完成签到,获得积分10
25秒前
QIU完成签到 ,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183449
求助须知:如何正确求助?哪些是违规求助? 9572834
关于积分的说明 21827509
捐赠科研通 7780646
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480371